{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,17]],"date-time":"2026-08-17T19:01:10Z","timestamp":1786993270439,"version":"build-2736575974"},"reference-count":56,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2015,9,1]],"date-time":"2015-09-01T00:00:00Z","timestamp":1441065600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":["clinicalkey.jp","clinicalkey.com","clinicalkey.es","clinicalkey.com.au","clinicalkey.fr","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of Psychiatric Research"],"published-print":{"date-parts":[[2015,9]]},"DOI":"10.1016\/j.jpsychires.2015.07.003","type":"journal-article","created":{"date-parts":[[2015,7,5]],"date-time":"2015-07-05T04:10:39Z","timestamp":1436069439000},"page":"210-216","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":61,"special_numbering":"C","title":["Oxidative stress in drug na\u00efve first episode psychosis and antioxidant effects of risperidone"],"prefix":"10.1016","volume":"68","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-2706-9118","authenticated-orcid":false,"given":"Cristiano","family":"Noto","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Vanessa Kiyomi","family":"Ota","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ary","family":"Gadelha","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mariane Nunes","family":"Noto","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"D\u00e9cio Sabbatini","family":"Barbosa","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kamila Landucci","family":"Bonif\u00e1cio","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sandra Odebrecht","family":"Nunes","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Quirino","family":"Cordeiro","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sintia Iole","family":"Belangero","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rodrigo Affonseca","family":"Bressan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Michael","family":"Maes","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Elisa","family":"Brietzke","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.jpsychires.2015.07.003_bib1","doi-asserted-by":"crossref","first-page":"247","DOI":"10.1016\/0920-9964(90)90005-R","article-title":"A\u00a0depression rating scale for schizophrenics","volume":"3","author":"Addington","year":"1990","journal-title":"Schizophr. Res."},{"key":"10.1016\/j.jpsychires.2015.07.003_bib2","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.pnpbp.2012.10.008","article-title":"Immuno-inflammatory, oxidative and nitrosative stress, and neuroprogressive pathways in the etiology, course and treatment of schizophrenia","volume":"42","author":"Anderson","year":"2013","journal-title":"Prog. Neuropsychopharmacol. Biol. Psychiatry"},{"key":"10.1016\/j.jpsychires.2015.07.003_bib3","doi-asserted-by":"crossref","first-page":"56","DOI":"10.1016\/S0006-3223(02)01443-9","article-title":"Essential polyunsaturated fatty acid and lipid peroxide levels in never-medicated and medicated schizophrenia patients","volume":"53","author":"Arvindakshan","year":"2003","journal-title":"Biol. Psychiatry"},{"key":"10.1016\/j.jpsychires.2015.07.003_bib4","first-page":"1","article-title":"Antidepressant and antipsychotic drugs differentially affect PON1 enzyme activity","author":"Avcikurt","year":"2014","journal-title":"J.\u00a0Enzyme Inhib Med. Chem."},{"key":"10.1016\/j.jpsychires.2015.07.003_bib5","doi-asserted-by":"crossref","first-page":"221","DOI":"10.1038\/nrn2054","article-title":"The neuropoietic cytokine family in development, plasticity, disease and injury","volume":"8","author":"Bauer","year":"2007","journal-title":"Nat. Rev. Neurosci."},{"key":"10.1016\/j.jpsychires.2015.07.003_bib6","doi-asserted-by":"crossref","first-page":"69","DOI":"10.1016\/j.schres.2005.05.019","article-title":"The many faces of nitric oxide in schizophrenia. A review","volume":"78","author":"Bernstein","year":"2005","journal-title":"Schizophr. Res."},{"key":"10.1016\/j.jpsychires.2015.07.003_bib7","doi-asserted-by":"crossref","first-page":"878","DOI":"10.1016\/j.neubiorev.2010.10.008","article-title":"Oxidative stress in schizophrenia: an integrated approach","volume":"35","author":"Bitanihirwe","year":"2011","journal-title":"Neurosci. Biobehav Rev."},{"key":"10.1016\/j.jpsychires.2015.07.003_bib8","doi-asserted-by":"crossref","first-page":"41","DOI":"10.1016\/S0920-9964(98)00029-2","article-title":"Validity study of the Brazilian version of the Calgary Depression Scale for Schizophrenia","volume":"32","author":"Bressan","year":"1998","journal-title":"Schizophr. Res."},{"key":"10.1016\/j.jpsychires.2015.07.003_bib9","doi-asserted-by":"crossref","first-page":"177","DOI":"10.1093\/schbul\/sbp073","article-title":"Brain anatomical abnormalities in high-risk individuals, first-episode, and chronic schizophrenia: an activation likelihood estimation meta-analysis of illness progression","volume":"37","author":"Chan","year":"2011","journal-title":"Schizophr. Bull."},{"key":"10.1016\/j.jpsychires.2015.07.003_bib10","doi-asserted-by":"crossref","first-page":"1350","DOI":"10.1001\/jamapsychiatry.2014.1314","article-title":"Cardiometabolic risk in patients with first-episode schizophrenia spectrum disorders: baseline results from the RAISE-ETP study","volume":"71","author":"Correll","year":"2014","journal-title":"JAMA Psychiatry"},{"key":"10.1016\/j.jpsychires.2015.07.003_bib11","doi-asserted-by":"crossref","first-page":"512","DOI":"10.1177\/0004867414533012","article-title":"Neuroprogression in schizophrenia: pathways underpinning clinical staging and therapeutic corollaries","volume":"48","author":"Davis","year":"2014","journal-title":"Aust. N. Z. J. Psychiatry"},{"key":"10.1016\/j.jpsychires.2015.07.003_bib12","doi-asserted-by":"crossref","first-page":"997","DOI":"10.1017\/S1461145710001410","article-title":"Understanding the role of inflammatory-related pathways in the pathophysiology and treatment of psychiatric disorders: evidence from human peripheral studies and CNS studies","volume":"14","author":"Dean","year":"2011","journal-title":"Int. J. Neuropsychopharmacol."},{"key":"10.1016\/j.jpsychires.2015.07.003_bib13","first-page":"170","article-title":"Paliperidone regulates intracellular redox system in rat brain: role of purine mechanism","volume":"20","author":"Demirci","year":"2015","journal-title":"Redox Rep. Commun. Free Radic. Res."},{"key":"10.1016\/j.jpsychires.2015.07.003_bib14","doi-asserted-by":"crossref","first-page":"33","DOI":"10.1007\/978-3-319-07320-0_5","article-title":"Inflammation, infection, cancer and all that...the role of paraoxonases","volume":"824","author":"Devarajan","year":"2014","journal-title":"Adv. Exp. Med. Biol."},{"key":"10.1016\/j.jpsychires.2015.07.003_bib15","doi-asserted-by":"crossref","first-page":"469","DOI":"10.1111\/j.1440-1819.2010.02132.x","article-title":"Lipid peroxidation in patients with schizophrenia","volume":"64","author":"Dietrich-Muszalska","year":"2010","journal-title":"Psychiatry Clin. Neurosci."},{"key":"10.1016\/j.jpsychires.2015.07.003_bib16","doi-asserted-by":"crossref","first-page":"90","DOI":"10.1080\/09537100802641499","article-title":"Modifications of blood platelet proteins of patients with schizophrenia","volume":"20","author":"Dietrich-Muszalska","year":"2009","journal-title":"Platelets"},{"key":"10.1016\/j.jpsychires.2015.07.003_bib17","doi-asserted-by":"crossref","first-page":"8","DOI":"10.1016\/S0006-3223(99)00092-X","article-title":"Essential fatty acids, lipid membrane abnormalities, and the diagnosis and treatment of schizophrenia","volume":"47","author":"Fenton","year":"2000","journal-title":"Biol. Psychiatry"},{"key":"10.1016\/j.jpsychires.2015.07.003_bib18","doi-asserted-by":"crossref","first-page":"4703","DOI":"10.1007\/s00213-014-3624-0","article-title":"A\u00a0study of antioxidant activity in patients with schizophrenia taking atypical antipsychotics","volume":"231","author":"Gilca","year":"2014","journal-title":"Psychopharmacol. (Berl)"},{"key":"10.1016\/j.jpsychires.2015.07.003_bib19","doi-asserted-by":"crossref","first-page":"1529","DOI":"10.1016\/S0022-2275(20)32182-9","article-title":"Lipid hydroperoxide generation, turnover, and effector action in biological systems","volume":"39","author":"Girotti","year":"1998","journal-title":"J.\u00a0Lipid Res."},{"key":"10.1016\/j.jpsychires.2015.07.003_bib20","doi-asserted-by":"crossref","first-page":"93","DOI":"10.1016\/0891-5849(91)90002-K","article-title":"Hydroperoxide-initiated chemiluminescence: an assay for oxidative stress in biopsies of heart, liver, and muscle","volume":"10","author":"Gonzalez Flecha","year":"1991","journal-title":"Free Radic. Biol. Med."},{"key":"10.1016\/j.jpsychires.2015.07.003_bib21","doi-asserted-by":"crossref","first-page":"33","DOI":"10.1146\/annurev.nu.16.070196.000341","article-title":"Antioxidants in human health and disease","volume":"16","author":"Halliwell","year":"1996","journal-title":"Annu. Rev. Nutr."},{"key":"10.1016\/j.jpsychires.2015.07.003_bib22","doi-asserted-by":"crossref","first-page":"901","DOI":"10.1016\/j.cca.2012.01.038","article-title":"Improved detection of advanced oxidation protein products in plasma","volume":"413","author":"Hanasand","year":"2012","journal-title":"Clin. Chim Acta Int. J. Clin. Chem."},{"key":"10.1016\/j.jpsychires.2015.07.003_bib23","doi-asserted-by":"crossref","first-page":"84","DOI":"10.1038\/mp.2014.66","article-title":"The neurobiology and treatment of first-episode schizophrenia","volume":"20","author":"Kahn","year":"2015","journal-title":"Mol. Psychiatry"},{"key":"10.1016\/j.jpsychires.2015.07.003_bib24","doi-asserted-by":"crossref","first-page":"261","DOI":"10.1093\/schbul\/13.2.261","article-title":"The positive and negative syndrome scale (PANSS) for schizophrenia","volume":"13","author":"Kay","year":"1987","journal-title":"Schizophr. Bull."},{"key":"10.1016\/j.jpsychires.2015.07.003_bib25","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/S0920-9964(01)00334-6","article-title":"Reduced erythrocyte membrane essential fatty acids and increased lipid peroxides in schizophrenia at the never-medicated first-episode of psychosis and after years of treatment with antipsychotics","volume":"58","author":"Khan","year":"2002","journal-title":"Schizophr. Res."},{"key":"10.1016\/j.jpsychires.2015.07.003_bib26","doi-asserted-by":"crossref","first-page":"273","DOI":"10.4088\/JCP.09r05268yel","article-title":"Antipsychotic medication and oxidative cell stress: a systematic review","volume":"72","author":"Lepping","year":"2011","journal-title":"J.\u00a0Clin. Psychiatry"},{"key":"10.1016\/j.jpsychires.2015.07.003_bib27","doi-asserted-by":"crossref","first-page":"7","DOI":"10.1111\/j.1600-0447.2008.01308.x","article-title":"Definitions of response and remission in schizophrenia: recommendations for their use and their presentation","author":"Leucht","year":"2009","journal-title":"Acta Psychiatr. Scand. Suppl."},{"key":"10.1016\/j.jpsychires.2015.07.003_bib28","doi-asserted-by":"crossref","first-page":"36","DOI":"10.1016\/j.ajp.2013.12.019","article-title":"Paraoxonase 1 activity and lipid profile in schizophrenic patients","volume":"9","author":"Mabrouk","year":"2014","journal-title":"Asian J. Psychiatry"},{"key":"10.1016\/j.jpsychires.2015.07.003_bib29","doi-asserted-by":"crossref","first-page":"676","DOI":"10.1016\/j.pnpbp.2010.05.004","article-title":"A\u00a0review on the oxidative and nitrosative stress (O&NS) pathways in major depression and their possible contribution to the (neuro)degenerative processes in that illness","volume":"35","author":"Maes","year":"2011","journal-title":"Prog. Neuropsychopharmacol. Biol. Psychiatry"},{"issue":"Suppl.\u00a02","key":"10.1016\/j.jpsychires.2015.07.003_bib30","doi-asserted-by":"crossref","first-page":"S149","DOI":"10.1016\/j.rbp.2012.07.001","article-title":"Nitric oxide plasma\/serum levels in patients with schizophrenia: a systematic review and meta-analysis","volume":"34","author":"Maia-de-Oliveira","year":"2012","journal-title":"Rev. Bras. Psiquiatr."},{"key":"10.1016\/j.jpsychires.2015.07.003_bib31","doi-asserted-by":"crossref","first-page":"20","DOI":"10.1016\/j.pnpbp.2011.11.003","article-title":"Developmental neuroinflammation and schizophrenia","volume":"42","author":"Meyer","year":"2013","journal-title":"Prog. Neuropsychopharmacol. Biol. Psychiatry"},{"key":"10.1016\/j.jpsychires.2015.07.003_bib32","doi-asserted-by":"crossref","first-page":"663","DOI":"10.1016\/j.biopsych.2011.04.013","article-title":"Meta-analysis of cytokine alterations in schizophrenia: clinical status and antipsychotic effects","volume":"70","author":"Miller","year":"2011","journal-title":"Biol. Psychiatry"},{"key":"10.1016\/j.jpsychires.2015.07.003_bib33","doi-asserted-by":"crossref","first-page":"46","DOI":"10.1016\/j.neubiorev.2014.05.007","article-title":"Oxidative & nitrosative stress in depression: why so much stress?","volume":"45","author":"Moylan","year":"2014","journal-title":"Neurosci. Biobehav Rev."},{"key":"10.1016\/j.jpsychires.2015.07.003_bib34","doi-asserted-by":"crossref","first-page":"679","DOI":"10.1093\/clinchem\/44.3.679","article-title":"Semiautomated measurement of nitrate in biological fluids","volume":"44","author":"Navarro-Gonzalvez","year":"1998","journal-title":"Clin. Chem."},{"issue":"4","key":"10.1016\/j.jpsychires.2015.07.003_bib35","doi-asserted-by":"crossref","DOI":"10.1093\/ijnp\/pyu042","article-title":"Effects of risperidone on cytokine profile in drug-naive first-episode psychosis","volume":"18","author":"Noto","year":"2015","journal-title":"Int. J. Neuropsychopharmacol"},{"key":"10.1016\/j.jpsychires.2015.07.003_bib36","doi-asserted-by":"crossref","first-page":"53","DOI":"10.1016\/j.schres.2015.01.026","article-title":"Effects of depression on the cytokine profile in drug naive first-episode psychosis","volume":"164","author":"Noto","year":"2015","journal-title":"Schizophr. Res."},{"key":"10.1016\/j.jpsychires.2015.07.003_bib37","doi-asserted-by":"crossref","first-page":"130","DOI":"10.1016\/j.jpsychires.2014.05.012","article-title":"Evaluation of neurotransmitter receptor gene expression identifies GABA receptor changes: a follow-up study in antipsychotic-naive patients with first-episode psychosis","volume":"56","author":"Ota","year":"2014","journal-title":"J.\u00a0Psychiatr. Res."},{"key":"10.1016\/j.jpsychires.2015.07.003_bib38","doi-asserted-by":"crossref","first-page":"358","DOI":"10.1016\/j.schres.2014.09.008","article-title":"Changes in gene expression and methylation in the blood of patients with first-episode psychosis","volume":"159","author":"Ota","year":"2014","journal-title":"Schizophr. Res."},{"key":"10.1016\/j.jpsychires.2015.07.003_bib39","doi-asserted-by":"crossref","first-page":"214","DOI":"10.1016\/j.pnpbp.2012.10.017","article-title":"Antioxidants as potential therapeutics for neuropsychiatric disorders","volume":"46","author":"Pandya","year":"2013","journal-title":"Prog. Neuropsychopharmacol. Biol. Psychiatry"},{"key":"10.1016\/j.jpsychires.2015.07.003_bib40","doi-asserted-by":"crossref","first-page":"89","DOI":"10.1007\/s10549-011-1693-x","article-title":"Oxidative stress and hematological profiles of advanced breast cancer patients subjected to paclitaxel or doxorubicin chemotherapy","volume":"133","author":"Panis","year":"2012","journal-title":"Breast Cancer Res. Treat."},{"key":"10.1016\/j.jpsychires.2015.07.003_bib41","doi-asserted-by":"crossref","first-page":"43","DOI":"10.1016\/S0022-3956(02)00048-1","article-title":"Differential effects of antipsychotics on expression of antioxidant enzymes and membrane lipid peroxidation in rat brain","volume":"37","author":"Parikh","year":"2003","journal-title":"J.\u00a0Psychiatr. Res."},{"key":"10.1016\/j.jpsychires.2015.07.003_bib42","doi-asserted-by":"crossref","first-page":"819","DOI":"10.1016\/j.jpsychires.2012.03.019","article-title":"Similarities in serum oxidative stress markers and inflammatory cytokines in patients with overt schizophrenia at early and late stages of chronicity","volume":"46","author":"Pedrini","year":"2012","journal-title":"J.\u00a0Psychiatr. Res."},{"key":"10.1016\/j.jpsychires.2015.07.003_bib43","doi-asserted-by":"crossref","first-page":"20","DOI":"10.1016\/j.atherosclerosis.2010.08.076","article-title":"The three-gene paraoxonase family: physiologic roles, actions and regulation","volume":"214","author":"Precourt","year":"2011","journal-title":"Atherosclerosis"},{"key":"10.1016\/j.jpsychires.2015.07.003_bib44","doi-asserted-by":"crossref","first-page":"107","DOI":"10.1016\/0009-8981(96)06394-2","article-title":"Oxidative stress in blood of HIV infected patients","volume":"255","author":"Repetto","year":"1996","journal-title":"Clin. Chim Acta Int. J. Clin. Chem."},{"key":"10.1016\/j.jpsychires.2015.07.003_bib45","doi-asserted-by":"crossref","first-page":"147","DOI":"10.1161\/CIRCGENETICS.108.811638","article-title":"Determination of paraoxonase 1 status without the use of toxic organophosphate substrates","volume":"1","author":"Richter","year":"2008","journal-title":"Circ. Cardiovasc. Genet."},{"key":"10.1016\/j.jpsychires.2015.07.003_bib46","doi-asserted-by":"crossref","first-page":"857","DOI":"10.1177\/0269881107077609","article-title":"Coronary artery disease risk factors in patients with schizophrenia: effects of short term antipsychotic treatment","volume":"21","author":"Sarandol","year":"2007","journal-title":"J.\u00a0Psychopharmacol."},{"key":"10.1016\/j.jpsychires.2015.07.003_bib47","doi-asserted-by":"crossref","first-page":"1115","DOI":"10.3109\/10715762.2011.602074","article-title":"Advanced oxidation protein products (AOPP): novel uremic toxins, or components of the non-enzymatic antioxidant system of the plasma proteome?","volume":"45","author":"Selmeci","year":"2011","journal-title":"Free Radic. Res."},{"key":"10.1016\/j.jpsychires.2015.07.003_bib48","doi-asserted-by":"crossref","first-page":"135","DOI":"10.1016\/0306-9877(95)90062-4","article-title":"The macrophage-T-lymphocyte theory of schizophrenia: additional evidence","volume":"45","author":"Smith","year":"1995","journal-title":"Med. Hypotheses"},{"key":"10.1016\/j.jpsychires.2015.07.003_bib49","article-title":"Antipsychotic-induced weight gain in first-episode psychosis patients: a meta-analysis of differential effects of antipsychotic medications","author":"Tek","year":"2015","journal-title":"Early Interv. Psychiatry"},{"key":"10.1016\/j.jpsychires.2015.07.003_bib50","first-page":"1545","article-title":"Reduced serum paraoxonase 1 (PON1) activity in patients with schizophrenia treated with olanzapine but not quetiapine","volume":"9","author":"Unsal","year":"2013","journal-title":"Neuropsychiatr. Dis. Treat."},{"key":"10.1016\/j.jpsychires.2015.07.003_bib51","doi-asserted-by":"crossref","first-page":"101","DOI":"10.1016\/j.schres.2014.03.005","article-title":"Cytokine function in medication-naive first episode psychosis: a systematic review and meta-analysis","volume":"155","author":"Upthegrove","year":"2014","journal-title":"Schizophr. Res."},{"key":"10.1016\/j.jpsychires.2015.07.003_bib52","doi-asserted-by":"crossref","first-page":"923","DOI":"10.1016\/j.jad.2013.05.016","article-title":"Oxidative stress and lowered total antioxidant status are associated with a history of suicide attempts","volume":"150","author":"Vargas","year":"2013","journal-title":"J.\u00a0Affect Disord."},{"key":"10.1016\/j.jpsychires.2015.07.003_bib53","first-page":"205","article-title":"Effect of alpha-lipoic acid supplementation on oxidative stress markers and antioxidative defense in patients with schizophrenia","volume":"26","author":"Vidovic","year":"2014","journal-title":"Psychiatr. Danub."},{"key":"10.1016\/j.jpsychires.2015.07.003_bib54","doi-asserted-by":"crossref","first-page":"795","DOI":"10.1002\/jnr.23360","article-title":"Neuroprotection of posttreatment with risperidone, an atypical antipsychotic drug, in rat and gerbil models of ischemic stroke and the maintenance of antioxidants in a gerbil model of ischemic stroke","volume":"92","author":"Yan","year":"2014","journal-title":"J.\u00a0Neurosci. Res."},{"key":"10.1016\/j.jpsychires.2015.07.003_bib55","doi-asserted-by":"crossref","first-page":"112","DOI":"10.1007\/s11427-010-0013-8","article-title":"A\u00a0meta-analysis of oxidative stress markers in schizophrenia","volume":"53","author":"Zhang","year":"2010","journal-title":"Sci. China Life Sci."},{"key":"10.1016\/j.jpsychires.2015.07.003_bib56","doi-asserted-by":"crossref","first-page":"1928","DOI":"10.1016\/j.neuropharm.2011.12.014","article-title":"Effects of risperidone and haloperidol on superoxide dismutase and nitric oxide in schizophrenia","volume":"62","author":"Zhang","year":"2012","journal-title":"Neuropharmacology"}],"container-title":["Journal of Psychiatric Research"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S002239561500196X?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S002239561500196X?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2021,4,4]],"date-time":"2021-04-04T17:41:22Z","timestamp":1617558082000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S002239561500196X"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2015,9]]},"references-count":56,"alternative-id":["S002239561500196X"],"URL":"https:\/\/doi.org\/10.1016\/j.jpsychires.2015.07.003","relation":{},"ISSN":["0022-3956"],"issn-type":[{"value":"0022-3956","type":"print"}],"subject":[],"published":{"date-parts":[[2015,9]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Oxidative stress in drug na\u00efve first episode psychosis and antioxidant effects of risperidone","name":"articletitle","label":"Article Title"},{"value":"Journal of Psychiatric Research","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jpsychires.2015.07.003","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2015 Elsevier Ltd. All rights reserved.","name":"copyright","label":"Copyright"}]}}